Copart [CPRT] vs Rentokil Initial plc [RTO] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Copart wins in 13 metrics, Rentokil Initial plc wins in 5 metrics, with 0 ties. Copart appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricCopartRentokil Initial plcBetter
P/E Ratio (TTM)30.4440.43Copart
Price-to-Book Ratio5.0912.19Copart
Debt-to-Equity Ratio1.13115.51Copart
PEG Ratio6.0943.91Copart
EV/EBITDA22.0471.26Copart
Profit Margin (TTM)33.41%4.46%Copart
Operating Margin (TTM)36.67%12.37%Copart
EBITDA Margin (TTM)36.67%12.37%Copart
Return on Equity18.48%5.13%Copart
Return on Assets (TTM)11.45%3.24%Copart
Free Cash Flow (TTM)$961.57M$627.24MCopart
Dividend YieldN/A2.50%N/A
1-Year Return-7.47%2.57%Rentokil Initial plc
Price-to-Sales Ratio (TTM)10.072.31Rentokil Initial plc
Enterprise Value$42.14B$93.04BRentokil Initial plc
EV/Revenue Ratio9.0712.40Copart
Gross Profit Margin (TTM)45.58%N/AN/A
Revenue per Share (TTM)$5$11Rentokil Initial plc
Earnings per Share (Diluted)$1.59$0.63Copart
Beta (Stock Volatility)1.030.32Rentokil Initial plc
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Copart vs Rentokil Initial plc Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Copart-2.16%-2.36%1.10%-1.63%-11.44%-15.48%
Rentokil Initial plc-0.60%-3.12%2.45%5.32%13.45%0.16%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Copart-7.47%79.42%82.59%1,012.15%2,145.28%3,275.89%
Rentokil Initial plc2.57%-7.03%-28.26%122.78%231.97%231.97%

News Based Sentiment: Copart vs Rentokil Initial plc

Copart

News based Sentiment: MIXED

Copart reported strong earnings and received a significant upgrade from HSBC, but the stock experienced volatility and the CEO's stock sale adds a layer of complexity. The mixed analyst sentiment and lack of FY26 guidance create some uncertainty, making this a moderately important month for investors.

View Copart News Sentiment Analysis

Rentokil Initial plc

News based Sentiment: MIXED

September brought a blend of positive developments – technical breakouts, institutional investment, and operational improvements – alongside ongoing integration complexities, mixed analyst views, and a high valuation. This creates a mixed investment narrative, making it a moderately significant month for the company.

View Rentokil Initial plc News Sentiment Analysis

Performance & Financial Health Analysis: Copart vs Rentokil Initial plc

MetricCPRTRTO
Market Information
Market Cap i$46.80B$14.02B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i7,964,660706,060
90 Day Avg. Volume i6,358,473793,817
Last Close$46.57$24.98
52 Week Range$45.05 - $64.38$19.60 - $27.37
% from 52W High-27.66%-8.73%
All-Time High$64.38 (Nov 25, 2024)$43.69 (Nov 08, 2021)
% from All-Time High-27.66%-42.82%
Growth Metrics
Quarterly Revenue Growth0.05%0.03%
Quarterly Earnings Growth0.23%-0.24%
Financial Health
Profit Margin (TTM) i0.33%0.04%
Operating Margin (TTM) i0.37%0.12%
Return on Equity (TTM) i0.18%0.05%
Debt to Equity (MRQ) i1.13115.51
Cash & Liquidity
Book Value per Share (MRQ)$9.50$2.09
Cash per Share (MRQ)$4.95$0.67
Operating Cash Flow (TTM) i$1.80B$1.02B
Levered Free Cash Flow (TTM) i$833.86M$420.11M
Dividends
Last 12-Month Dividend Yield iN/A2.50%
Last 12-Month Dividend iN/A$0.58

Valuation & Enterprise Metrics Analysis: Copart vs Rentokil Initial plc

MetricCPRTRTO
Price Ratios
P/E Ratio (TTM) i30.4440.43
Forward P/E i27.8243.91
PEG Ratio i6.0943.91
Price to Sales (TTM) i10.072.31
Price to Book (MRQ) i5.0912.19
Market Capitalization
Market Capitalization i$46.80B$14.02B
Enterprise Value i$42.14B$93.04B
Enterprise Value Metrics
Enterprise to Revenue i9.0712.40
Enterprise to EBITDA i22.0471.26
Risk & Other Metrics
Beta i1.030.32
Book Value per Share (MRQ) i$9.50$2.09

Financial Statements Comparison: Copart vs Rentokil Initial plc

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CPRTRTO
Revenue/Sales i$1.21BN/A
Cost of Goods Sold i$659.45MN/A
Gross Profit i$552.27MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$451.55MN/A
EBITDA i$506.07MN/A
Pre-Tax Income i$502.80MN/A
Income Tax i$97.47MN/A
Net Income (Profit) i$405.34MN/A

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CPRTRTO
Cash & Equivalents i$2.37B$1.23B
Total Current Assets i$5.36B$2.83B
Total Current Liabilities i$657.13M$3.49B
Long-Term Debt i$81.27M$3.81B
Total Shareholders Equity i$8.80B$5.73B
Retained Earnings i$7.70B$4.89B
Property, Plant & Equipment i$97.68M$829.10M

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CPRTRTO
Operating Cash Flow i$704.64MN/A
Capital Expenditures i$-124.08MN/A
Free Cash Flow i$572.92MN/A
Debt Repayment i$-4,000N/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricCPRTRTO
Shares Short i26.34M3.52M
Short Ratio i4.723.60
Short % of Float i0.03%0.01%
Average Daily Volume (10 Day) i7,964,660706,060
Average Daily Volume (90 Day) i6,358,473793,817
Shares Outstanding i962.97M3.41B
Float Shares i886.61M2.28B
% Held by Insiders i0.09%0.00%
% Held by Institutions i0.87%0.13%

Dividend Analysis & Yield Comparison: Copart vs Rentokil Initial plc

MetricCPRTRTO
Last 12-Month Dividend iN/A$0.58
Last 12-Month Dividend Yield iN/A2.50%
3-Year Avg Annual Dividend iN/A$0.53
3-Year Avg Dividend Yield iN/A0.88%
3-Year Total Dividends iN/A$1.58
Ex-Dividend DateN/AApr 04, 2025